Digitalization, modeling, and simulation are reshaping how biopharmaceutical processes are designed, scaled, and transferred, from lab to commercial manufacturing.

This webinar explores how in silico modeling can act as a surrogate for traditional process development, helping define design spaces, identify critical parameters, and predict performance before costly cGMP runs.

From mechanistic and data-driven models to digital twins and regulatory expectations, the session provides a practical, experience-based view on integrating modeling into CMC strategy and lifecycle management.

Featuring Bikash Chatterjee, President and Chief Science Officer, Pharmatech Associates, and Nima Yazdanpanah, Principal, Procegence.